Amplifi Vascular closed a $6.8M Series A to scale operations and accelerate development of its vein dilation system aimed at improving arteriovenous fistula creation and maturation for hemodialysis patients. Backers were not disclosed in the announcement.
Comments
Want to join the conversation?
Loading comments...